1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow MSI: new trials by email Literature Review of MSI trials Research Report on MSI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer FOLFOX regimen, FOLFIRI Protocol, Avelumab - Metastatic Colorectal Cancer, MSI | Phase 2 | Completed | Federation Francophone de Cancerologie Digestive | 132 | 2018-04-24 | 2025-06-29 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Bevacizumab (1) · Cetuximab (1) · Folfox protocol (1) · IFL protocol (1) · Panitumumab (1) · aflibercept (1) · avelumab (1)
Federation Francophone de Cancerologie Digestive (1)
France (1)
Julien Taieb, Pr (1)